#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates


The emergence of viral respiratory pathogens with pandemic potential, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and influenza A H5N1, urges the need for deciphering their pathogenesis to develop new intervention strategies. SARS-CoV infection causes acute lung injury (ALI) that may develop into life-threatening acute respiratory distress syndrome (ARDS) with advanced age correlating positively with adverse disease outcome. The molecular pathways, however, that cause virus-induced ALI/ARDS in aged individuals are ill-defined. Here, we show that SARS-CoV-infected aged macaques develop more severe pathology than young adult animals, even though viral replication levels are similar. Comprehensive genomic analyses indicate that aged macaques have a stronger host response to virus infection than young adult macaques, with an increase in differential expression of genes associated with inflammation, with NF-κB as central player, whereas expression of type I interferon (IFN)-β is reduced. Therapeutic treatment of SARS-CoV-infected aged macaques with type I IFN reduces pathology and diminishes pro-inflammatory gene expression, including interleukin-8 (IL-8) levels, without affecting virus replication in the lungs. Thus, ALI in SARS-CoV-infected aged macaques developed as a result of an exacerbated innate host response. The anti-inflammatory action of type I IFN reveals a potential intervention strategy for virus-induced ALI.


Vyšlo v časopise: Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates. PLoS Pathog 6(2): e32767. doi:10.1371/journal.ppat.1000756
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000756

Souhrn

The emergence of viral respiratory pathogens with pandemic potential, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and influenza A H5N1, urges the need for deciphering their pathogenesis to develop new intervention strategies. SARS-CoV infection causes acute lung injury (ALI) that may develop into life-threatening acute respiratory distress syndrome (ARDS) with advanced age correlating positively with adverse disease outcome. The molecular pathways, however, that cause virus-induced ALI/ARDS in aged individuals are ill-defined. Here, we show that SARS-CoV-infected aged macaques develop more severe pathology than young adult animals, even though viral replication levels are similar. Comprehensive genomic analyses indicate that aged macaques have a stronger host response to virus infection than young adult macaques, with an increase in differential expression of genes associated with inflammation, with NF-κB as central player, whereas expression of type I interferon (IFN)-β is reduced. Therapeutic treatment of SARS-CoV-infected aged macaques with type I IFN reduces pathology and diminishes pro-inflammatory gene expression, including interleukin-8 (IL-8) levels, without affecting virus replication in the lungs. Thus, ALI in SARS-CoV-infected aged macaques developed as a result of an exacerbated innate host response. The anti-inflammatory action of type I IFN reveals a potential intervention strategy for virus-induced ALI.


Zdroje

1. LicastroF

CandoreG

LioD

PorcelliniE

Colonna-RomanoG

2005 Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2 8

2. MeyerKC

2005 Aging. Proc Am Thorac Soc 2 433 439

3. PlackettTP

BoehmerED

FaunceDE

KovacsEJ

2004 Aging and innate immune cells. J Leukoc Biol 76 291 299

4. MeyerKC

2001 The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol 128 23 31

5. PeirisJS

ChuCM

ChengVC

ChanKS

HungIF

2003 Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 1767 1772

6. PeirisJS

GuanY

YuenKY

2004 Severe acute respiratory syndrome. Nat Med 10 S88 97

7. HuangKJ

SuIJ

TheronM

WuYC

LaiSK

2005 An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 75 185 194

8. JiangY

XuJ

ZhouC

WuZ

ZhongS

2005 Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 171 850 857

9. WareLB

MatthayMA

2000 The acute respiratory distress syndrome. N Engl J Med 342 1334 1349

10. HonKL

LeungCW

ChengWT

ChanPK

ChuWC

2003 Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 361 1701 1703

11. LeungCW

ChiuWK

2004 Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children. Paediatr Respir Rev 5 275 288

12. WongGW

LiAM

NgPC

FokTF

2003 Severe acute respiratory syndrome in children. Pediatr Pulmonol 36 261 266

13. CameronMJ

RanL

XuL

DaneshA

Bermejo-MartinJF

2007 Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 81 8692 8706

14. NagataN

IwataN

HasegawaH

FukushiS

YokoyamaM

2007 Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol 81 1848 1857

15. TangNL

ChanPK

WongCK

ToKF

WuAK

2005 Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem 51 2333 2340

16. WongCK

LamCW

WuAK

IpWK

LeeNL

2004 Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136 95 103

17. CheungCY

PoonLL

NgIH

LukW

SiaSF

2005 Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 79 7819 7826

18. LawHK

CheungCY

NgHY

SiaSF

ChanYO

2005 Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106 2366 2374

19. de LangA

BaasT

TealT

LeijtenLM

RainB

2007 Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. PLoS Pathog 3 e112 doi:10.1371/journal.ppat.0030112

20. WareLB

2005 Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 33 S217 222

21. FouchierRA

KuikenT

SchuttenM

van AmerongenG

van DoornumGJ

2003 Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423 240

22. HaagmansBL

KuikenT

MartinaBE

FouchierRA

RimmelzwaanGF

2004 Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 10 290 293

23. KuikenT

FouchierRA

SchuttenM

RimmelzwaanGF

van AmerongenG

2003 Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362 263 270

24. FanJ

YeRD

MalikAB

2001 Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281 L1037 1050

25. ImaiY

KubaK

NeelyGG

Yaghubian-MalhamiR

PerkmannT

2008 Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133 235 249

26. GoemanJJ

van de GeerSA

de KortF

van HouwelingenHC

2004 A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 20 93 99

27. FolkessonHG

MatthayMA

HebertCA

BroaddusVC

1995 Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 96 107 116

28. ModelskaK

PittetJF

FolkessonHG

Courtney BroaddusV

MatthayMA

1999 Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am J Respir Crit Care Med 160 1450 1456

29. AmitI

GarberM

ChevrierN

LeiteAP

DonnerY

2009 Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326 257 263

30. KramerOH

BausD

KnauerSK

SteinS

JagerE

2006 Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev 20 473 485

31. AkiraS

UematsuS

TakeuchiO

2006 Pathogen recognition and innate immunity. Cell 124 783 801

32. AuronPE

1998 The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev 9 221 237

33. HaagmansBL

OsterhausADME

2006 Nonhuman primate models for SARS. PLoS Med 3 e194 doi:10.1371/journal.pmed.0030194

34. ChungHY

SungB

JungKJ

ZouY

YuBP

2006 The molecular inflammatory process in aging. Antioxid Redox Signal 8 572 581

35. RutkuteK

AsmisRH

Nikolova-KarakashianMN

2007 Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation. J Lipid Res 48 2443 2452

36. GasseP

MaryC

GuenonI

NoulinN

CharronS

2007 IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 117 3786 3799

37. AwD

SilvaAB

PalmerDB

2007 Immunosenescence: emerging challenges for an ageing population. Immunology 120 435 446

38. BruunsgaardH

PedersenM

PedersenBK

2001 Aging and proinflammatory cytokines. Curr Opin Hematol 8 131 136

39. FranceschiC

BonafeM

ValensinS

OlivieriF

De LucaM

2000 Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908 244 254

40. FangX

GaoJ

ZhengH

LiB

KongL

2007 The membrane protein of SARS-CoV suppresses NF-kappaB activation. J Med Virol 79 1431 1439

41. FriemanM

HeiseM

BaricR

2008 SARS coronavirus and innate immunity. Virus Res 133 101 112

42. Kopecky-BrombergSA

Martinez-SobridoL

FriemanM

BaricRA

PaleseP

2007 Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81 548 557

43. BaasT

RobertsA

TealTH

VogelL

ChenJ

2008 Genomic Analysis Reveals Age Dependent Innate Immune Responses to SARS Coronavirus. J Virol 82 9465 9476

44. RockxB

BaasT

ZornetzerGA

HaagmansB

SheahanT

2009 Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol 83 7062 7074

45. Cervantes-BarraganL

ZustR

WeberF

SpiegelM

LangKS

2007 Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109 1131 1137

46. KongKF

DelrouxK

WangX

QianF

ArjonaA

2008 Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 82 7613 7623

47. RinkL

CakmanI

KirchnerH

1998 Altered cytokine production in the elderly. Mech Ageing Dev 102 199 209

48. YoonP

KeylockKT

HartmanME

FreundGG

WoodsJA

2004 Macrophage hypo-responsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT. Mech Ageing Dev 125 137 143

49. PrinzM

SchmidtH

MildnerA

KnobelochKP

HanischUK

2008 Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28 675 686

50. AbreuSL

1982 Suppression of experimental allergic encephalomyelitis by interferon. Immunol Commun 11 1 7

51. BilliauA

2006 Anti-inflammatory properties of Type I interferons. Antiviral Res 71 108 116

52. GuoB

ChangEY

ChengG

2008 The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest 118 1680 1690

53. van HoltenJ

ReedquistK

Sattonet-RocheP

SmeetsTJ

Plater-ZyberkC

2004 Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther 6 R239 249

54. NozellS

LaverT

PatelK

BenvenisteEN

2006 Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells. J Immunol 177 822 830

55. O'NeillLA

2008 When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29 12 20

56. RothlinCV

GhoshS

ZunigaEI

OldstoneMB

LemkeG

2007 TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131 1124 1136

57. AmanMJ

TretterT

EisenbeisI

BugG

DeckerT

1996 Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood 87 4731 4736

58. GansterRW

GuoZ

ShaoL

GellerDA

2005 Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions. J Interferon Cytokine Res 25 707 719

59. PauliEK

SchmolkeM

WolffT

ViemannD

RothJ

2008 Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4 e1000196 doi:10.1371/journal.ppat.1000196

60. WeiL

SandbulteMR

ThomasPG

WebbyRJ

HomayouniR

2006 NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem 281 11678 11684

61. NagataN

IwataN

HasegawaH

FukushiS

HarashimaA

2008 Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am J Pathol 172 1625 1637

62. LoutfyMR

BlattLM

SiminovitchKA

WardS

WolffB

2003 Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. Jama 290 3222 3228

63. LivakKJ

SchmittgenTD

2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402 408

64. HuberW

von HeydebreckA

SultmannH

PoustkaA

VingronM

2002 Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 Suppl 1 S96 104

65. TukeyJW

1977 Some thoughts on clinical trials, especially problems of multiplicity. Science 198 679 684

66. SmythGK

2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 Article3

67. BenjaminiY

HochbergY

1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Soc B 57 289 300

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#